A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

An Open Label Phase 4 Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.

Drug interaction study

Inclusion Criteria:

• Healthy male and/or female subjects between 18 and 55 years of age.

Exclusion Criteria:

• Evidence or history of clinically significant disease or clinical findings at screening